SALT LAKE CITY, Dec. 14 /PRNewswire/ -- RemedyMD(R), an innovator in the field of clinical research information systems, today announced the production release of Translate(TM) for Clinical Investigators (CI). Translate(TM) is a powerful, comprehensive offering that dramatically improves the efficiency of clinical investigators.
Translate(TM) is engineered on a robust information platform that integrates clinical data from disparate sources-such as clinical data stored in an Electronic Medical Record systems-into a centralized, researchable data repository. Translate uses RemedyMD's patent-pending SMART(TM) interfaces to gather and reconcile clinical data from customers' various electronic health information systems. By drawing upon multiple clinical information systems as inputs, and storing them in a central repository using current medical technology standards, Translate powers predictive outcomes tracking and retrospective data analysis.
"The need to aggregate data from multiple sources has been limiting the efficiency of clinical researchers" said Dr. Roberto A. Rocha, RemedyMD's CMO and Lead Informaticist. "Translate(TM) is capable of integrating EHR data from hospitals and physicians with arbitrary sets of research data collected on narrowly defined cohorts."
Translate(TM) supports and integrates all research activities, from study protocol creation to data analysis and publication. As a web-based solution backed by a robust data aggregation engine, Translate includes a scalable, secure data repository that supports consistent research of rich clinical data. Using Translate, clinical investigators can streamline communication among study participants, collaborate with other researchers, and significantly decrease the effort required to set up and manage a clinical research study.
Translate is closely tied to RemedyMD's myHealthManager(TM), a consumer-oriented health management portal designed specifically for patients to record their health history and interact with researchers. By using Translate, clinical investigators can spend less time micromanaging data and study details, and more time focusing on patients, disease pathways, treatment regimens and valuable clinical knowledge.
"Outcome tracking has become a primary focus in recent years among the research community," said Gary Kennedy, Chairman and CEO of RemedyMD. "Both retrospective and prospective outcome tracking studies are strongly supported by the Translate platform. Translate was designed specifically for the needs associated with these studies."
RemedyMD will ship the first production release of Translate(TM) in mid-January of 2007 to existing and new customers.
About RemedyMD
RemedyMD is transforming healthcare by delivering intelligent, decision-support software that enables medical professionals to make better decisions-ultimately leading to better outcomes. Using RemedyMD, physicians are reviewing the latest patient and research trends at the point of care; researchers are introducing point-of-care information into their medical studies; and patients are receiving more relevant, personalized information as they take greater responsibility for their own health. Using predictive informatics, RemedyMD is helping professionals take preemptive actions, reducing the system-wide cost of healthcare. RemedyMD web-based software has a low cost of ownership and is personalized to specific practices and medical specialties. For more information, visit www.RemedyMD.com or call 877-REMEDY9.
RemedyMDCONTACT: Holly Holm, +1-801-733-3364, hholm@RemedyMD.com; Nathan Hulse,+1-801-733-3364, nhulse@remedymd.com
Web site: http://www.remedymd.com/
